Clinical Trials Browser

Phase 3 × Gastric Cancer Stage × tislelizumab × Clear all

NCT07068516 2025-07-16

Perioperative Tislelizumab Plus Chemotherapy Versus Chemotherapy Alone in MHC-II-Positive Gastric/GEJ Cancer

Phase 3 Not yet recruiting

Gastrointestinal

Gastric Cancer Stage